PEAK6 Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$1.5M Buy
+25,000
New +$1.35M 0.01% 1616
2018
Q1
Sell
-15,300
Closed -$804K 4478
2017
Q4
$804K Sell
15,300
-5,600
-27% -$299K ﹤0.01% 2093
2017
Q3
$985K Sell
20,900
-19,700
-49% -$793K 0.01% 1978
2017
Q2
$1.44M Sell
40,600
-700
-2% -$21.6K 0.01% 1617
2017
Q1
$976K Buy
+41,300
New +$818K 0.01% 1704
2016
Q4
Sell
-22,100
Closed -$410K 4809
2016
Q3
$410K Sell
22,100
-103,300
-82% -$1.82M ﹤0.01% 2518
2016
Q2
$1.54M Buy
+125,400
New +$945K 0.01% 1451

Other funds holding EXAS

PEAK6 Group's EXAS Position: Q2 2018 in Review

PEAK6 Group sold out of Exact Sciences (EXAS) in Q2 2018, closing a stake of 16,985 shares — an estimated $914K sold.

PEAK6 Group first reported a position in EXAS in Q4 2017 and held it in 2 quarters. The position peaked at $685K in Q1 2018. 348 funds tracked by Wall St. Rank hold EXAS as of Q2 2018.

  • PEAK6 Group reported no remaining Exact Sciences position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 16,985 Exact Sciences shares in Q2 2018, an estimated $914K.
  • PEAK6 Group first reported a position in Exact Sciences in Q4 2017 and held it in 2 quarters.
  • PEAK6 Group's Exact Sciences position peaked at $685K in Q1 2018.
  • 348 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.